The Short Answer
Bruker (BRKR) has a qualitative business verdict that is HALAL and passes the known filing-based financial ratios, but the overall screen remains incomplete. Bruker is a leading manufacturer of high-performance scientific instruments and analytical solutions.
Scientific-instrument manufacturing is generally permissible at the activity level. The March 31, 2026 filing reports debt/assets of 27.26%, below the examined 33% limits; the activity numerator remains qualitative.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
1,671.3 / 6,130.7
133.4 / 6,130.7
676.1 / 6,130.7
4.9 / 823.4
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 27.26%, liquidity/assets is 2.18%, receivables-plus-cash/assets is 11.03% and disclosed interest income is 0.60%; business activity remains qualitative.
- Financial
- Pass
- Overall
- Incomplete
Debt, liquidity and receivables-plus-cash ratios are below the examined MSCI limits; this is not an index-membership claim and activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets and identifiable liquidity/assets are below the examined Malaysia limits; this is a calculation against SAC ratios, not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored; filing-based asset ratios remain documented.
Business-activity disclosure
Bruker designs and manufactures scientific instruments and analytical systems including magnetic resonance, mass spectrometry, X-ray, microscopy and spectroscopy tools for research, life-science and applied markets. The core activity is generally permissible, but the filing does not provide a universal prohibited-revenue numerator for downstream uses.
Limitation: No universal prohibited-activity revenue numerator or scholar-specific purification percentage is disclosed; end-market use remains qualitative.
Purification
The filing discloses $4.9 million of interest income; ZakatInvest does not prescribe a fixed scholar-approved purification percentage.
Inputs, assumptions and primary sources
- Amounts are USD millions from Bruker's March 31, 2026 Form 10-Q.
- Current long-term debt and finance-lease obligations are $8.4 million and long-term debt is $1,662.9 million; operating leases are excluded.
- Cash and cash equivalents are $133.4 million; no separately identified interest-bearing security balance is added; receivables, net are $542.7 million.
- First-quarter revenue is $823.4 million and reported interest income is $4.9 million (0.60% of revenue).
- Scientific-instrument activity is retained as qualitative analysis; no universal prohibited-revenue numerator is disclosed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Sharia Screening Methodology
Islamic scholars use several criteria to screen stocks:
- Business activity screen: Is the company's primary business halal?
- Debt ratio: Total debt / market cap must be under 33%
- Interest income: Interest income / total revenue must be under 5%
- Haram revenue: Revenue from haram sources must be under 5%
- Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)
Bruker's Business Activity
Bruker designs, manufactures, and sells:
- Analytical instruments: Magnetic-resonance (NMR), mass-spectrometry, and X-ray systems
- Microscopy and spectroscopy: Fluorescence-microscopy, infrared, and Raman systems
- Life-science and applied tools: Instruments for pharmaceutical, biotech, and clinical-research markets
These are general-purpose scientific-instrument and research-tools businesses — manufacturing engineered measurement equipment. This is permissible at the activity level.
Concerns to Be Aware Of
1. Leverage Profile
Bruker has taken on additional debt to fund a series of acquisitions. The debt-to-market-cap ratio should be verified against the 33% threshold at the time of investment, and the financial screen should be re-verified following material acquisitions.
2. End-Market Look-Through
Bruker's instruments are sold into mixed-Sharia-profile end-markets (academic-research, pharmaceutical, biotech, applied-industrial, and clinical). Under standard methodology, the relevant classification is general-purpose scientific-instrument manufacturing rather than the look-through end-customer mix.
3. Minor Interest Income
The filing reports $4.9 million of interest income, or 0.60% of quarterly revenue. ZakatInvest does not prescribe a fixed purification percentage.
Filing-Based Ratios (March 31, 2026)
Using the latest Bruker Form 10-Q (USD millions):
- Debt / total assets: 27.26%
- Cash + securities / total assets: 2.18%
- Receivables + cash / total assets: 11.03%
- Disclosed interest income / revenue: 0.60%
Methodology Interpretation
These are ZakatInvest calculations from the cited filing, not claims of current index membership or an official scholar ruling:
- FTSE-style: Known financial ratios pass; activity remains qualitative.
- MSCI-style: Known financial ratios pass; this is not an index-membership claim.
- Malaysia-style: Known debt and liquidity ratios pass; this is not an official classification.
Bottom Line
Bruker (BRKR) has a generally permissible scientific-instrument business and passes the known filing-based ratios. Because no universal prohibited-revenue numerator is disclosed, the overall result remains incomplete rather than a universal halal certification; re-check after acquisitions and consult the methodology you follow.
For Muslim investors seeking scientific-instrument and test-and-measurement exposure, BRKR sits alongside other halal-screened names like AMETEK (AME) and Teledyne (TDY).
Want to check if another stock is halal? Use our free screener.
Open Halal Checker →